MIRXES-B

02629
12.4100.00% ( 0.000 )
Delay Suspended: Nov 17, 16:08:15

Profile

About

MIRXES-B
MIRXES-B
02629.HK

Mirxes Holding Company Limited, a micro ribonucleic acid technology company, provides diagnostic solutions for the screening of cancer, cardiovascular, metabolic, and infectious diseases accessible across Singapore and China. The company offers GASTROClear, a blood-based miRNA detection panel consisting of 12 miRNA biomarkers for gastric cancer screening; LUNGClear, a lung cancer screening product candidate; and Fortitude COVID-19 RT-qPCR test kits. It also researches, develops, and manufactures biotechnology, life, and medical science related products. The company was founded in 2014 and is headquartered in Singapore.

Profile

Company Name
Mirxes Holding Company Limited
Market
SEHK
Founded
Industry
--
Fiscal Year End
December 31
Website
mirxes.com

Related Securities

Industry

Management